摘要
目的探讨福辛普利联用虫草菌粉治疗2型糖尿病肾病早期的临床使用价值。方法选取糖尿病肾病早期患者120例,随机分为两组。实验组采用福辛普利联用虫草菌粉治疗,对照组单用福辛普利治疗,用药周期半年。治疗期间,测量与记录患者用药前后24 h的尿微量白蛋白排泄量(UAE),统计内生肌酐的清除率(CCr)。结果治疗后,实验组UAE有效率95.0%显著高于对照组61.7%(P<0.05);实验组CCr值显著低于对照组(P<0.01)。结论福辛普利联用虫草菌粉治疗早期2型糖尿病肾病效果更为显著,值得推广。
Objective To explore the effect of Fosinopril combined with Jinshuibao therapy of early type 2 diabetic nephropathy patients with clinical use value. Methods The selection of patients with early diabetih nephropathy 120 cases were randomly divided into two groups. The experimental group with Phusimpson leigh combined with Jinshui- bao treatment,control group only with Phusimpson leigh treatment, medication cycle for half a year. During treatment, measure and record the patients before and after treatment of urinary albumin excretion in 24 h （UAE）,creatinine clearance rate statistics （CCr）. Results After treatment,UAE of the experimental group was significantly lower than that of control group, the effective rate was 95.0%, 61.7% （P 〈 0.05）; statistical CCr found, the experimental group was significantly lower than that in control group （P 〈 0.01 ）. Conclusion The effects of Phusimpson leigh combined with Jinshui bao in treatment of early diabetic nephropathy in type 2 diabetes mellitus effect is more significant,is worth popularizing.
出处
《中国现代医生》
2013年第2期60-61,共2页
China Modern Doctor
关键词
福辛普利
虫草菌粉
2型糖尿病肾病
Phusimpson leigh
Jinshuibao
Type 2 diabetic nephropathy
